Skip to main content
. 2020 Apr 28;12(5):1095. doi: 10.3390/cancers12051095

Table 1.

Cell line genetic abnormalities.

Cell Line MYCN Status 11q Status (Genes Deleted) p53 Status Reference
SHSY5Y Non-amp No deletion WT [34]
SKNAS Non-amp Deletion (MRE11, ATM, CHEK1, H2AFX) Mutant Deletion of intron9/exon 10 [35,36]
NGP Amp Deletion (ATM, CHEK1, H2AFX) WT [36]
N20_R1 Amp Deletion ** (ATM, CHEK1, H2AFX) Mutant P98H P152T [37]
NMB * Amp Deletion (MRE11, ATM, CHEK1, H2AFX) Mutant G245S [36,38]
IMR32 Amp Deletion (ATM, CHEK1, H2AFX) ATM mutant V2716A WT [39,40]
IMR32/Kat100 (Kat100) Amp Unknown Mutant C135F [41]
IGRN91 Amp No deletion Mutant Duplication of exons 7–9 [42,43]
SJNB1 * Non-amp Deletion (MRE11, ATM, CHEK1, H2AFX) WT [36]
GIMEN Non-amp Deletion (MRE11, ATM, CHEK1, H2AFX) WT [36]

Amp: amplified, Non-amp: non-amplified, WT: wild type; * cell line is near tetraploid [44], Chr11 LOH; ** derived from NGP, assume same.